Black men in the United States are more likely to be diagnosed with and to die from prostate cancer vs. men of other backgrounds. They are diagnosed at a younger age and with more advanced disease. Yet, Black men remained a footnote in national prostate cancer screening guidelines. These stark, basic facts led PCF to convene a panel of renowned experts in the fields of urology, medical oncology, disparities research, primary care, and epidemiology. They were charged with surveying the complete body of research to develop evidence-based screening recommendations. The resulting guidelines are tr ..read more

  View transcript here. Dr. Martin Schoen of St. Louis University and the St. Louis VA Medical Center led a recently published study showing that over the past 20 years, patients diagnosed with metastatic prostate cancer are living longer. Many new medicines for advanced prostate cancer have been developed over the past 2 decades. Dr. Schoen notes that we see that these drugs have prolonged survival in clinical trials, but his team wanted to understand whether this was also true for the average patient being treated in the “real world.” The researchers used data from the VA and from the ..read more

Identifying a pathway to improve outcomes for men with high-risk localised and metastatic hormone sensitive prostate cancer. Movember is partnering with the ICECaP Consortium to leverage the natural alignment of our shared goal to accelerate global progress on a strategic approach that can significantly reduce the number of men dying from prostate cancer. Please join us in this fourth webinar for an update on the progress from five ICECaP working groups. TUESDAY MAY 14TH 2024 Pacific Daylight Time (PDT) > 1PM – 3PM Eastern Daylight Time (EDT) > 4PM – 6PM British Summer Time (BST) > 9P ..read more

Nothing says spring like pesto! Along with this delicious basil sauce, the Prostate Cancer Foundation’s April recipe includes chicken, tomato, garlic, and even more basil. It’s healthy and a hit at any dinner party! Research shows that dietary factors can help to reduce the risk of developing advanced prostate cancer in patients after diagnosis, including eating cruciferous vegetables (think broccoli, certain leafy greens, Brussels sprouts, etc.) tomatoes, and olive oil, and avoiding foods such as whole milk and red and processed meats. With this recipe, you’ll adhere to these nutrition goals ..read more

The Prostate Cancer Foundation would like to thank Dr. Collins for going public with his prostate cancer diagnosis, spurring men and families to talk about prostate cancer and to understand its urgency. Few leaders have done more to advance human health and biomedical research than Dr. Francis Collins. By sharing his perspective and family story, he raises the vitally important consideration of how prostate cancer can run in families. He helps raise critical awareness for thousands of men at higher risk who might not otherwise have considered their potential risk. Additionally, he sets an exce ..read more

Annual prostate cancer cases are projected to rise from 1.4 million in 2020 to 2.9 million in 2040, and annual deaths to increase by 85% to almost 700,000 over the same timeframe, mainly among men in low-and middle-income countries (LMICs). The Lancet Commission on prostate cancer argues that the ‘informed choice’ programme for prostate cancer screening with PSA testing, which is common in high-income countries (HICs), may lead to over-testing and unnecessary treatment in older men, and under-testing in high-risk younger men. The authors advocate instead for early-detection programmes for tho ..read more

The Prostate Cancer Foundation Scholar-in-Training Awards recognize promising young cancer researchers presenting outstanding proffered papers relating to advanced prostate cancer at the American Association for Cancer Research (AACR) Annual Meeting. The Prostate Cancer Foundation is one of 13 organizations sponsoring this highly competitive awards program in conjunction with the AACR. The 2024 AACR Annual Meeting will be held from April 5-10 in San Diego, CA. CheukMan Cherie Au, PhD, Weill Cornell Medicine, New York, NY. Abstract # 1231. First-in-class AR-V7/AR-fl small molecule molecular glu ..read more

It is with deep sadness that we announce that our beloved and esteemed friend and colleague, Dr. Charles “Chuck” Chan passed away on March 12, 2024, at the age of 48. Chuck has been a member of the Prostate Cancer Foundation (PCF) Community since he obtained a PCF Young Investigator Award in 2013, to understand how metastatic prostate cancer cells invade and survive in the bone marrow and identify new methods to therapeutically target bone metastases, when he was a postdoctoral fellow in the Irving Weissman and Michael Longaker Laboratories at Stanford University. At the time of his passing, C ..read more

**To download photos and video from the PCF check presentation, click here.**   FOR IMMEDIATE RELEASE: 3/23/24 CONTACT: Max Strauss, Atlanta Hawks Brand Communications, brandcomms@hawks.com   ATLANTA HAWKS FOUNDATION AND RESSLER GERTZ FAMILY FOUNDATION TEAM UP TO DONATE $150,000 TO PROSTATE CANCER FOUNDATION Nearly a Million Dollars Raised Since 2019 to Raise Awareness and Support Research of Prostate Cancer ATLANTA – Before tonight’s game, the Atlanta Hawks Foundation, along with the Ressler Gertz Family Foundation, announced a donation of $150,0000 to support the Prostate Cancer F ..read more

The U.S. Department of Veterans Affairs (VA) has two weapons of unprecedented power that are already having a mighty effect on cancer research and treatment:  its sheer magnitude and its infrastructure.  With 1,323 VA care sites and 173 medical centers across the U.S. and a massive patient population of about 9 million, the VA also has the longest-working electronic health record in the country, going back more than 25 years. In a remarkable partnership, PCF and the VA have established 21 VA Prostate Cancer Centers of Excellence where, on the treatment side, Veterans have access to g ..read more